Evidence map›Paper›PMID 26457296›Full record

ReviewBioMed research international2015

Adverse Psychiatric Effects Associated with Herbal Weight-Loss Products.

F Saverio Bersani, Marialuce Coviello, Claudio Imperatori, Marta Francesconi, Christina M Hough, Giuseppe Valeriani, Gianfranco De Stefano, Flaminia Bolzan Mariotti Posocco, Rita Santacroce, Amedeo Minichino and 1 more

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
10.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

F Saverio BersaniDepartment of Neurology and Psychiatry, Sapienza University of Rome, 00185 Rome, Italy ; School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK.
Marialuce CovielloDepartment of Neurology and Psychiatry, Sapienza University of Rome, 00185 Rome, Italy.
Claudio ImperatoriDepartment of Human Sciences, European University of Rome, 00163 Rome, Italy.
Marta FrancesconiDepartment of Neurology and Psychiatry, Sapienza University of Rome, 00185 Rome, Italy.
Christina M HoughDepartment of Psychiatry, University of California San Francisco, San Francisco, CA 94143, USA.
Giuseppe ValerianiDepartment of Neurology and Psychiatry, Sapienza University of Rome, 00185 Rome, Italy ; School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK ; Department of Psychiatry, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden.
Gianfranco De StefanoDepartment of Neurology and Psychiatry, Sapienza University of Rome, 00185 Rome, Italy.
Flaminia Bolzan Mariotti PosoccoInternational Association for Applied Human Sciences, 00100 Rome, Italy.
Rita SantacroceSchool of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK ; Department of Neuroscience and Imaging, Gabriele D'Annunzio University, 66100 Chieti, Italy.
Amedeo MinichinoDepartment of Neurology and Psychiatry, Sapienza University of Rome, 00185 Rome, Italy.
Ornella CorazzaSchool of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK.
Sapienza University of Rome · ITUniversity of Hertfordshire · GBEuropean University of Rome · ITUniversity of California, San Francisco · USUniversity of Chieti-Pescara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity and overeating are among the most prevalent health concerns worldwide and individuals are increasingly using performance and image-enhancing drugs (PIEDs) as an easy and fast way to control their weight. Among these, herbal weight-loss products (HWLPs) often attract users due to their health claims, assumed safety, easy availability, affordable price, extensive marketing, and the perceived lack of need for professional oversight. Reports suggest that certain HWLPs may lead to onset or exacerbation of psychiatric disturbances. Here we review the available evidence on psychiatric adverse effects of HWLPs due to their intrinsic toxicity and potential for interaction with psychiatric medications.

Indexed as

Anti-Obesity AgentsHumansMental DisordersPlants, MedicinalAnti-Obesity Agents

Identifiers

PMID26457296
PMCPMC4589574
OpenAlexW2127723147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.